Large-scale testing (Phase 3)Study completedNCT05397600
What this trial is testing
Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients
Who this might be right for
GlaucomaOcular Hypertension
Laboratoires Thea 684